MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Unsuitable for MCA as hygroscopic buccal tablets, which should not be swallowed.

Provenance

This compatibility recommendation is derived from Effentora buccal tablets (Teva UK Ltd).

Stability Notes

Unsuitable for MCA as hygroscopic buccal tablets, which should not be swallowed.

Provenance

This compatibility recommendation is derived from Effentora buccal tablets (Teva UK Ltd).

Stability Notes

Unsuitable for MCA as hygroscopic buccal tablets, which should not be swallowed.

Provenance

This compatibility recommendation is derived from Effentora buccal tablets (Teva UK Ltd).

Stability Notes

Unsuitable for MCA as hygroscopic buccal tablets, which should not be swallowed.

Provenance

This compatibility recommendation is derived from Effentora buccal tablets (Teva UK Ltd).

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Efracea 40mg modified-release capsules (Galderma (UK) Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.